The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Tenofovir Alafenamide Fumarate Market Research Report 2025
Synopsis
Tenofovir alafenamide hemifumarate, also known as Tenofovir alafenamide fumarate (2:1), is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevents HIV from multiplying and can reduce the amount of HIV in the body.
The global Tenofovir Alafenamide Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tenofovir Alafenamide Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tenofovir Alafenamide Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tenofovir Alafenamide Fumarate include AFINE CHEMICALS LIMITED, BOC Sciences, ENBRIDGE PHARMTECH, SimSon Pharma Limited, Valorpharm and Watson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tenofovir Alafenamide Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Alafenamide Fumarate.
Report Scope
The Tenofovir Alafenamide Fumarate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tenofovir Alafenamide Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Alafenamide Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AFINE CHEMICALS LIMITED
BOC Sciences
ENBRIDGE PHARMTECH
SimSon Pharma Limited
Valorpharm
Watson
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Segment by Application
Medicine
Chemical Industry
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenofovir Alafenamide Fumarate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tenofovir Alafenamide Fumarate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tenofovir Alafenamide Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Tenofovir alafenamide hemifumarate, also known as Tenofovir alafenamide fumarate (2:1), is a nucleotide reverse transcriptase inhibitor (NRTIs) and a novel prodrug of tenofovir. By blocking reverse transcriptase, TAF prevents HIV from multiplying and can reduce the amount of HIV in the body.
The global Tenofovir Alafenamide Fumarate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Tenofovir Alafenamide Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tenofovir Alafenamide Fumarate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Tenofovir Alafenamide Fumarate include AFINE CHEMICALS LIMITED, BOC Sciences, ENBRIDGE PHARMTECH, SimSon Pharma Limited, Valorpharm and Watson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tenofovir Alafenamide Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Alafenamide Fumarate.
Report Scope
The Tenofovir Alafenamide Fumarate market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tenofovir Alafenamide Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Alafenamide Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AFINE CHEMICALS LIMITED
BOC Sciences
ENBRIDGE PHARMTECH
SimSon Pharma Limited
Valorpharm
Watson
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Segment by Application
Medicine
Chemical Industry
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tenofovir Alafenamide Fumarate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Tenofovir Alafenamide Fumarate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Tenofovir Alafenamide Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Tenofovir Alafenamide Fumarate Market Overview
1.1 Product Definition
1.2 Tenofovir Alafenamide Fumarate Segment by Type
1.2.1 Global Tenofovir Alafenamide Fumarate Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.3 Tenofovir Alafenamide Fumarate Segment by Application
1.3.1 Global Tenofovir Alafenamide Fumarate Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Medicine
1.3.3 Chemical Industry
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Tenofovir Alafenamide Fumarate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Tenofovir Alafenamide Fumarate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Tenofovir Alafenamide Fumarate Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Tenofovir Alafenamide Fumarate Production Market Share by Manufacturers (2019-2024)
2.2 Global Tenofovir Alafenamide Fumarate Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Tenofovir Alafenamide Fumarate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Tenofovir Alafenamide Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Tenofovir Alafenamide Fumarate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Tenofovir Alafenamide Fumarate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Tenofovir Alafenamide Fumarate, Product Offered and Application
2.8 Global Key Manufacturers of Tenofovir Alafenamide Fumarate, Date of Enter into This Industry
2.9 Tenofovir Alafenamide Fumarate Market Competitive Situation and Trends
2.9.1 Tenofovir Alafenamide Fumarate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Tenofovir Alafenamide Fumarate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Tenofovir Alafenamide Fumarate Production by Region
3.1 Global Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Tenofovir Alafenamide Fumarate Production Value by Region (2019-2030)
3.2.1 Global Tenofovir Alafenamide Fumarate Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Tenofovir Alafenamide Fumarate by Region (2025-2030)
3.3 Global Tenofovir Alafenamide Fumarate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Tenofovir Alafenamide Fumarate Production by Region (2019-2030)
3.4.1 Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Tenofovir Alafenamide Fumarate by Region (2025-2030)
3.5 Global Tenofovir Alafenamide Fumarate Market Price Analysis by Region (2019-2024)
3.6 Global Tenofovir Alafenamide Fumarate Production and Value, Year-over-Year Growth
3.6.1 North America Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Tenofovir Alafenamide Fumarate Production Value Estimates and Forecasts (2019-2030)
4 Tenofovir Alafenamide Fumarate Consumption by Region
4.1 Global Tenofovir Alafenamide Fumarate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Tenofovir Alafenamide Fumarate Consumption by Region (2019-2030)
4.2.1 Global Tenofovir Alafenamide Fumarate Consumption by Region (2019-2024)
4.2.2 Global Tenofovir Alafenamide Fumarate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Tenofovir Alafenamide Fumarate Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Tenofovir Alafenamide Fumarate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Tenofovir Alafenamide Fumarate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Tenofovir Alafenamide Fumarate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Tenofovir Alafenamide Fumarate Production by Type (2019-2030)
5.1.1 Global Tenofovir Alafenamide Fumarate Production by Type (2019-2024)
5.1.2 Global Tenofovir Alafenamide Fumarate Production by Type (2025-2030)
5.1.3 Global Tenofovir Alafenamide Fumarate Production Market Share by Type (2019-2030)
5.2 Global Tenofovir Alafenamide Fumarate Production Value by Type (2019-2030)
5.2.1 Global Tenofovir Alafenamide Fumarate Production Value by Type (2019-2024)
5.2.2 Global Tenofovir Alafenamide Fumarate Production Value by Type (2025-2030)
5.2.3 Global Tenofovir Alafenamide Fumarate Production Value Market Share by Type (2019-2030)
5.3 Global Tenofovir Alafenamide Fumarate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Tenofovir Alafenamide Fumarate Production by Application (2019-2030)
6.1.1 Global Tenofovir Alafenamide Fumarate Production by Application (2019-2024)
6.1.2 Global Tenofovir Alafenamide Fumarate Production by Application (2025-2030)
6.1.3 Global Tenofovir Alafenamide Fumarate Production Market Share by Application (2019-2030)
6.2 Global Tenofovir Alafenamide Fumarate Production Value by Application (2019-2030)
6.2.1 Global Tenofovir Alafenamide Fumarate Production Value by Application (2019-2024)
6.2.2 Global Tenofovir Alafenamide Fumarate Production Value by Application (2025-2030)
6.2.3 Global Tenofovir Alafenamide Fumarate Production Value Market Share by Application (2019-2030)
6.3 Global Tenofovir Alafenamide Fumarate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 AFINE CHEMICALS LIMITED
7.1.1 AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Corporation Information
7.1.2 AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Product Portfolio
7.1.3 AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 AFINE CHEMICALS LIMITED Main Business and Markets Served
7.1.5 AFINE CHEMICALS LIMITED Recent Developments/Updates
7.2 BOC Sciences
7.2.1 BOC Sciences Tenofovir Alafenamide Fumarate Corporation Information
7.2.2 BOC Sciences Tenofovir Alafenamide Fumarate Product Portfolio
7.2.3 BOC Sciences Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 BOC Sciences Main Business and Markets Served
7.2.5 BOC Sciences Recent Developments/Updates
7.3 ENBRIDGE PHARMTECH
7.3.1 ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Corporation Information
7.3.2 ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Product Portfolio
7.3.3 ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 ENBRIDGE PHARMTECH Main Business and Markets Served
7.3.5 ENBRIDGE PHARMTECH Recent Developments/Updates
7.4 SimSon Pharma Limited
7.4.1 SimSon Pharma Limited Tenofovir Alafenamide Fumarate Corporation Information
7.4.2 SimSon Pharma Limited Tenofovir Alafenamide Fumarate Product Portfolio
7.4.3 SimSon Pharma Limited Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 SimSon Pharma Limited Main Business and Markets Served
7.4.5 SimSon Pharma Limited Recent Developments/Updates
7.5 Valorpharm
7.5.1 Valorpharm Tenofovir Alafenamide Fumarate Corporation Information
7.5.2 Valorpharm Tenofovir Alafenamide Fumarate Product Portfolio
7.5.3 Valorpharm Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Valorpharm Main Business and Markets Served
7.5.5 Valorpharm Recent Developments/Updates
7.6 Watson
7.6.1 Watson Tenofovir Alafenamide Fumarate Corporation Information
7.6.2 Watson Tenofovir Alafenamide Fumarate Product Portfolio
7.6.3 Watson Tenofovir Alafenamide Fumarate Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Watson Main Business and Markets Served
7.6.5 Watson Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Tenofovir Alafenamide Fumarate Industry Chain Analysis
8.2 Tenofovir Alafenamide Fumarate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Tenofovir Alafenamide Fumarate Production Mode & Process
8.4 Tenofovir Alafenamide Fumarate Sales and Marketing
8.4.1 Tenofovir Alafenamide Fumarate Sales Channels
8.4.2 Tenofovir Alafenamide Fumarate Distributors
8.5 Tenofovir Alafenamide Fumarate Customers
9 Tenofovir Alafenamide Fumarate Market Dynamics
9.1 Tenofovir Alafenamide Fumarate Industry Trends
9.2 Tenofovir Alafenamide Fumarate Market Drivers
9.3 Tenofovir Alafenamide Fumarate Market Challenges
9.4 Tenofovir Alafenamide Fumarate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Tenofovir Alafenamide Fumarate Market Value by Type, (US$ Million) & (2023 VS 2030)
Table 2. Global Tenofovir Alafenamide Fumarate Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global Tenofovir Alafenamide Fumarate Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global Tenofovir Alafenamide Fumarate Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global Tenofovir Alafenamide Fumarate Production Market Share by Manufacturers (2019-2024)
Table 6. Global Tenofovir Alafenamide Fumarate Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global Tenofovir Alafenamide Fumarate Production Value Share by Manufacturers (2019-2024)
Table 8. Global Tenofovir Alafenamide Fumarate Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tenofovir Alafenamide Fumarate as of 2023)
Table 10. Global Market Tenofovir Alafenamide Fumarate Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers Tenofovir Alafenamide Fumarate Production Sites and Area Served
Table 12. Manufacturers Tenofovir Alafenamide Fumarate Product Types
Table 13. Global Tenofovir Alafenamide Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global Tenofovir Alafenamide Fumarate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) by Region (2019-2024)
Table 17. Global Tenofovir Alafenamide Fumarate Production Value Market Share by Region (2019-2024)
Table 18. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global Tenofovir Alafenamide Fumarate Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global Tenofovir Alafenamide Fumarate Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global Tenofovir Alafenamide Fumarate Production (Tons) by Region (2019-2024)
Table 22. Global Tenofovir Alafenamide Fumarate Production Market Share by Region (2019-2024)
Table 23. Global Tenofovir Alafenamide Fumarate Production (Tons) Forecast by Region (2025-2030)
Table 24. Global Tenofovir Alafenamide Fumarate Production Market Share Forecast by Region (2025-2030)
Table 25. Global Tenofovir Alafenamide Fumarate Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global Tenofovir Alafenamide Fumarate Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global Tenofovir Alafenamide Fumarate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global Tenofovir Alafenamide Fumarate Consumption by Region (2019-2024) & (Tons)
Table 29. Global Tenofovir Alafenamide Fumarate Consumption Market Share by Region (2019-2024)
Table 30. Global Tenofovir Alafenamide Fumarate Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global Tenofovir Alafenamide Fumarate Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America Tenofovir Alafenamide Fumarate Consumption by Country (2019-2024) & (Tons)
Table 34. North America Tenofovir Alafenamide Fumarate Consumption by Country (2025-2030) & (Tons)
Table 35. Europe Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe Tenofovir Alafenamide Fumarate Consumption by Country (2019-2024) & (Tons)
Table 37. Europe Tenofovir Alafenamide Fumarate Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific Tenofovir Alafenamide Fumarate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific Tenofovir Alafenamide Fumarate Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific Tenofovir Alafenamide Fumarate Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption by Country (2025-2030) & (Tons)
Table 44. Global Tenofovir Alafenamide Fumarate Production (Tons) by Type (2019-2024)
Table 45. Global Tenofovir Alafenamide Fumarate Production (Tons) by Type (2025-2030)
Table 46. Global Tenofovir Alafenamide Fumarate Production Market Share by Type (2019-2024)
Table 47. Global Tenofovir Alafenamide Fumarate Production Market Share by Type (2025-2030)
Table 48. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) by Type (2019-2024)
Table 49. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) by Type (2025-2030)
Table 50. Global Tenofovir Alafenamide Fumarate Production Value Share by Type (2019-2024)
Table 51. Global Tenofovir Alafenamide Fumarate Production Value Share by Type (2025-2030)
Table 52. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Type (2019-2024)
Table 53. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Type (2025-2030)
Table 54. Global Tenofovir Alafenamide Fumarate Production (Tons) by Application (2019-2024)
Table 55. Global Tenofovir Alafenamide Fumarate Production (Tons) by Application (2025-2030)
Table 56. Global Tenofovir Alafenamide Fumarate Production Market Share by Application (2019-2024)
Table 57. Global Tenofovir Alafenamide Fumarate Production Market Share by Application (2025-2030)
Table 58. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) by Application (2019-2024)
Table 59. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) by Application (2025-2030)
Table 60. Global Tenofovir Alafenamide Fumarate Production Value Share by Application (2019-2024)
Table 61. Global Tenofovir Alafenamide Fumarate Production Value Share by Application (2025-2030)
Table 62. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Application (2019-2024)
Table 63. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Application (2025-2030)
Table 64. AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Corporation Information
Table 65. AFINE CHEMICALS LIMITED Specification and Application
Table 66. AFINE CHEMICALS LIMITED Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. AFINE CHEMICALS LIMITED Main Business and Markets Served
Table 68. AFINE CHEMICALS LIMITED Recent Developments/Updates
Table 69. BOC Sciences Tenofovir Alafenamide Fumarate Corporation Information
Table 70. BOC Sciences Specification and Application
Table 71. BOC Sciences Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. BOC Sciences Main Business and Markets Served
Table 73. BOC Sciences Recent Developments/Updates
Table 74. ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Corporation Information
Table 75. ENBRIDGE PHARMTECH Specification and Application
Table 76. ENBRIDGE PHARMTECH Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. ENBRIDGE PHARMTECH Main Business and Markets Served
Table 78. ENBRIDGE PHARMTECH Recent Developments/Updates
Table 79. SimSon Pharma Limited Tenofovir Alafenamide Fumarate Corporation Information
Table 80. SimSon Pharma Limited Specification and Application
Table 81. SimSon Pharma Limited Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. SimSon Pharma Limited Main Business and Markets Served
Table 83. SimSon Pharma Limited Recent Developments/Updates
Table 84. Valorpharm Tenofovir Alafenamide Fumarate Corporation Information
Table 85. Valorpharm Specification and Application
Table 86. Valorpharm Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Valorpharm Main Business and Markets Served
Table 88. Valorpharm Recent Developments/Updates
Table 89. Watson Tenofovir Alafenamide Fumarate Corporation Information
Table 90. Watson Specification and Application
Table 91. Watson Tenofovir Alafenamide Fumarate Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Watson Main Business and Markets Served
Table 93. Watson Recent Developments/Updates
Table 94. Key Raw Materials Lists
Table 95. Raw Materials Key Suppliers Lists
Table 96. Tenofovir Alafenamide Fumarate Distributors List
Table 97. Tenofovir Alafenamide Fumarate Customers List
Table 98. Tenofovir Alafenamide Fumarate Market Trends
Table 99. Tenofovir Alafenamide Fumarate Market Drivers
Table 100. Tenofovir Alafenamide Fumarate Market Challenges
Table 101. Tenofovir Alafenamide Fumarate Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Tenofovir Alafenamide Fumarate
Figure 2. Global Tenofovir Alafenamide Fumarate Market Value by Type, (US$ Million) & (2023 VS 2030)
Figure 3. Global Tenofovir Alafenamide Fumarate Market Share by Type: 2023 VS 2030
Figure 4. Purity 97% Product Picture
Figure 5. Purity 98% Product Picture
Figure 6. Purity 99% Product Picture
Figure 7. Global Tenofovir Alafenamide Fumarate Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 8. Global Tenofovir Alafenamide Fumarate Market Share by Application: 2023 VS 2030
Figure 9. Medicine
Figure 10. Chemical Industry
Figure 11. Others
Figure 12. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tenofovir Alafenamide Fumarate Production Value (US$ Million) & (2019-2030)
Figure 14. Global Tenofovir Alafenamide Fumarate Production Capacity (Tons) & (2019-2030)
Figure 15. Global Tenofovir Alafenamide Fumarate Production (Tons) & (2019-2030)
Figure 16. Global Tenofovir Alafenamide Fumarate Average Price (US$/Ton) & (2019-2030)
Figure 17. Tenofovir Alafenamide Fumarate Report Years Considered
Figure 18. Tenofovir Alafenamide Fumarate Production Share by Manufacturers in 2023
Figure 19. Tenofovir Alafenamide Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. The Global 5 and 10 Largest Players: Market Share by Tenofovir Alafenamide Fumarate Revenue in 2023
Figure 21. Global Tenofovir Alafenamide Fumarate Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Tenofovir Alafenamide Fumarate Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. Global Tenofovir Alafenamide Fumarate Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 24. Global Tenofovir Alafenamide Fumarate Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. North America Tenofovir Alafenamide Fumarate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Europe Tenofovir Alafenamide Fumarate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. China Tenofovir Alafenamide Fumarate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Japan Tenofovir Alafenamide Fumarate Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global Tenofovir Alafenamide Fumarate Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 30. Global Tenofovir Alafenamide Fumarate Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 32. North America Tenofovir Alafenamide Fumarate Consumption Market Share by Country (2019-2030)
Figure 33. Canada Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. U.S. Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 35. Europe Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 36. Europe Tenofovir Alafenamide Fumarate Consumption Market Share by Country (2019-2030)
Figure 37. Germany Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. France Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. U.K. Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. Italy Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Russia Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Asia Pacific Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 43. Asia Pacific Tenofovir Alafenamide Fumarate Consumption Market Share by Regions (2019-2030)
Figure 44. China Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. Japan Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. South Korea Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. China Taiwan Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. Southeast Asia Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. India Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 51. Latin America, Middle East & Africa Tenofovir Alafenamide Fumarate Consumption Market Share by Country (2019-2030)
Figure 52. Mexico Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. Brazil Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. Turkey Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. GCC Countries Tenofovir Alafenamide Fumarate Consumption and Growth Rate (2019-2024) & (Tons)
Figure 56. Global Production Market Share of Tenofovir Alafenamide Fumarate by Type (2019-2030)
Figure 57. Global Production Value Market Share of Tenofovir Alafenamide Fumarate by Type (2019-2030)
Figure 58. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Type (2019-2030)
Figure 59. Global Production Market Share of Tenofovir Alafenamide Fumarate by Application (2019-2030)
Figure 60. Global Production Value Market Share of Tenofovir Alafenamide Fumarate by Application (2019-2030)
Figure 61. Global Tenofovir Alafenamide Fumarate Price (US$/Ton) by Application (2019-2030)
Figure 62. Tenofovir Alafenamide Fumarate Value Chain
Figure 63. Tenofovir Alafenamide Fumarate Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
